Kymera Therapeutics Other Current Liability (Quarterly) Analysis

Kymera Therapeutics, Inc. (KYMR)

73.09 -1.68 (-2.25%) USD | NASDAQ | Jan 12, 16:00

73.01 -0.08 (-0.11%) After-Hours: 20:00

View Other Current Liability (Quarterly) for KYMR.
Upgrade now.

Sep '18

Jan '19

May '19

285.00

270.00

255.00

240.00

View Other Current Liability (Quarterly) Chart

Start Trial

View Historical Data

Start Trial

View Other Current Liability (Quarterly) Range, Past 5 Years

Start Trial

Minimum

Maximum

Average

Median

View Other Current Liability (Quarterly) Benchmarks

Start Trial

Regeneron Pharmaceuticals, Inc.	--
Gilead Sciences, Inc.	Upgrade
Cytokinetics, Inc.	Upgrade
TG Therapeutics, Inc.	Upgrade
Protagonist Therapeutics, Inc.	--